REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 45 filers reported holding REDHILL BIOPHARMA LTD in Q4 2019. The put-call ratio across all filers is 1.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $6,280,000 | -74.3% | 1,034,650 | -70.2% | 0.72% | -73.6% |
| Q3 2019 | $24,472,000 | +1.9% | 3,476,039 | -5.9% | 2.72% | +24.6% |
| Q2 2019 | $24,010,000 | -21.8% | 3,693,840 | 0.0% | 2.18% | -21.6% |
| Q1 2019 | $30,696,000 | +49.7% | 3,693,840 | 0.0% | 2.78% | +124.2% |
| Q4 2018 | $20,501,000 | -36.1% | 3,693,840 | +1.7% | 1.24% | -40.3% |
| Q3 2018 | $32,062,000 | +84.0% | 3,631,019 | +77.8% | 2.08% | +76.8% |
| Q2 2018 | $17,424,000 | +103.3% | 2,042,654 | +22.8% | 1.18% | +55.5% |
| Q1 2018 | $8,569,000 | +66.8% | 1,663,903 | +66.5% | 0.76% | +74.8% |
| Q4 2017 | $5,136,000 | – | 999,232 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 300 | $2,175 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |